Mario arrived on life support — ultra-rapid WGS confirmed why he needed a heart transplant
We are heading up a newborn sequencing consortium that will revolutionize and shorten the diagnostic journey.
We’re setting a new standard of care for newborns and children with rare undiagnosed diseases.
Rady Childrens Institute for Genomic Medicine (RCIGM), a non-profit research institute enabling rapid diagnosis and targeted treatment of critically ill newborns and pediatric patients, is proud to announce that Aaron D. Besterman, MD, received a Young Investigator Grant from the Brain & Behavior Research Foundation.
PATIENT WORTHY: Catherine Nester spoke with Patient Worthy about the importance of newborn screening, the challenges of diagnostic delays, and how Inozyme is working to transform the treatment landscape for ENPP1 Deficiency and ABCC6 Deficiency, also known as Generalized Arterial Calcification of Infancy (GACI) types 1 and 2, respectively.
WASHINGTON POST: DNA sequencing to diagnose newborns could end up saving much more money — especially if done for babies who are sick. In a study funded by the state of California called Project Baby Bear, researcher Stephen Kingsmore found that sequencing the whole genomes of 178 infants hospitalized in intensive care saved $2.5 million.
Wednesday January 24, 2024 | 3pm PST
Rapid Precision Medicine™ is here now. We are setting the standard for pediatric critical care by breaking barriers to expand access to genomically-informed, personalized care nationwide. We offer many opportunities to collaborate with as we work to save and improve lives.
© 2023 Rady Children's Institute for Genomic Medicine.
